Subsequent verification revealed that METTL16 knockdown resulted in reduced Soga1 mRNA levels, whereas METTL16 over‐expression increased Soga1 mRNA levels in CRC cells (Figure 4C,D). The gene discussed is MTCL2; the disease is colorectal carcinoma.